Truntzer C, Thibaudin M, Bousquet PA, Peroz M, Derangère V, Ilie A, Rageot D, Flatmark K, Ree AH, Meltzer S, Ghiringhelli F (2026)
Pooled analysis of 2 clinical trials of first-line chemoimmunotherapy for metastatic microsatellite stable colorectal cancer MEDITREME and METIMMOX studies
Oncoimmunology, 15 (1), 2671491
DOI 10.1080/2162402X.2026.2671491, PubMed 42322272

Ree AH, Meltzer S, Flatmark K, Dueland S (2026)
Low-intensity induction chemotherapy before chemoradiotherapy for rectal cancer: 10-year overall survival in the LARC-RRP trial
Br J Radiol (in press)
DOI 10.1093/bjr/tqag133, PubMed 42233285

Meltzer S, Landmark SS, Šaltytė Benth J, Negård A, Hamre HM, Kersten C, Hofsli E, Guren MG, Sorbye H, Flatmark K, Ree AH (2026)
Carcinoembryonic Antigen Flare Under Oxaliplatin-Based Chemotherapy Predicts Benefit from Nivolumab in Metastatic Microsatellite-Stable Colorectal Cancer - A Post Hoc Analysis of METIMMOX Trial Data
Immunotargets Ther, 15, 594176
DOI 10.2147/ITT.S594176, PubMed 42158080